Hypopituitarism surgery: Difference between revisions
Jump to navigation
Jump to search
Iqra Qamar (talk | contribs) |
Iqra Qamar (talk | contribs) |
||
| Line 3: | Line 3: | ||
{{CMG}}; {{AE}} | {{CMG}}; {{AE}} | ||
==Overview== | ==Overview:== | ||
The feasibility of surgery depends on the clinical condition and underlying etiology. Following conditions need a surgical consideration: pituitary apoplexy , microadenomas with GH or ACTH hyper secretion and debulking macroadenomas with mass symptoms and resistant to medical therapy | |||
==Surgery== | ==Surgery== | ||
| Line 17: | Line 12: | ||
==Indications== | ==Indications== | ||
Following conditions need a surgical consideration: | Following conditions need a surgical consideration: | ||
Pituitary apoplexy Microadenomas with GH or ACTH hyper secretion Debulking macroadenomas with mass symptoms and resistant to medical therapy | * Pituitary apoplexy | ||
* Microadenomas with GH or ACTH hyper secretion | |||
* Debulking macroadenomas with mass symptoms and resistant to medical therapy | |||
==References== | ==References== | ||
Revision as of 18:31, 11 September 2017
|
Hypopituitarism Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Hypopituitarism surgery On the Web |
|
American Roentgen Ray Society Images of Hypopituitarism surgery |
|
Risk calculators and risk factors for Hypopituitarism surgery |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief:
Overview:
The feasibility of surgery depends on the clinical condition and underlying etiology. Following conditions need a surgical consideration: pituitary apoplexy , microadenomas with GH or ACTH hyper secretion and debulking macroadenomas with mass symptoms and resistant to medical therapy
Surgery
- A study showed that non-functioning pituitary adenomas may be prevented from recurrence by gross-total resection and/or adjuvant radiotherapy.[1]
- Literature review has shown better outcomes with endoscopic transsphenoidal surgery when compared to microscopic technique in gross tumor removal as it lowers the risk of CSF leak, septal perforation, infection, hematoma, hypopituitarism, recurrence, and overall mortality. [2][3][4]
Indications
Following conditions need a surgical consideration:
- Pituitary apoplexy
- Microadenomas with GH or ACTH hyper secretion
- Debulking macroadenomas with mass symptoms and resistant to medical therapy
References
- ↑ Lee MH, Lee JH, Seol HJ, Lee JI, Kim JH, Kong DS, Nam DH (2016). "Clinical Concerns about Recurrence of Non-Functioning Pituitary Adenoma". Brain Tumor Res Treat. 4 (1): 1–7. doi:10.14791/btrt.2016.4.1.1. PMC 4868810. PMID 27195254.
- ↑ Esquenazi Y, Essayed WI, Singh H, Mauer E, Ahmed M, Christos PJ, Schwartz TH (2017). "Endoscopic Endonasal Versus Microscopic Transsphenoidal Surgery for Recurrent and/or Residual Pituitary Adenomas". World Neurosurg. 101: 186–195. doi:10.1016/j.wneu.2017.01.110. PMID 28185971.
- ↑ Li A, Liu W, Cao P, Zheng Y, Bu Z, Zhou T (2017). "Endoscopic Versus Microscopic Transsphenoidal Surgery in the Treatment of Pituitary Adenoma: A Systematic Review and Meta-Analysis". World Neurosurg. 101: 236–246. doi:10.1016/j.wneu.2017.01.022. PMID 28104521.
- ↑ Zhu M, Yang J, Wang Y, Cao W, Zhu Y, Qiu L, Tao Y, Xu Y, Xu H (2014). "[Endoscopic transsphenoidal surgery versus microsurgery for the resection of pituitary adenomas: a systematic review]". Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi (in Chinese). 49 (3): 236–9. PMID 24820497.